NANBIOSIS participated in an EDIH Madrid Region 2.0 training session on R&D&I funding, helping organizations identify funding opportunities to accelerate innovation.
Barcelona, June 2026 — Last month, NANBIOSIS took part in the “R&D&I Funding Search” training course organized by EDIH Madrid Region 2.0, an initiative designed to help companies, public administrations and research organizations navigate the wide range of public and private funding opportunities available for innovation projects.
The in-person event, held in Madrid and delivered by Matical Innovation, provided participants with practical guidance on identifying funding opportunities and developing strategic plans to support research, development and innovation (R&D&I) activities.
Throughout the session, attendees explored the main national and regional funding programmes available in Spain, together with the requirements for accessing public support. The course also introduced methodologies for identifying an organization’s R&D capabilities and innovation assets that could be further developed through funded projects.
The programme covered a broad range of topics, including direct and indirect public funding instruments, tax incentives for R&D&I, and strategies for combining different financial resources to maximise project impact. Participants also received an introduction to European funding opportunities, including Horizon Europe, public-private partnerships and cascade funding schemes, as well as private investment options such as venture capital, crowdfunding and business accelerators.
The training concluded with a practical session focused on preparing strategic R&D&I funding plans, enabling participants to identify funding opportunities tailored to their own organizations.
As a research infrastructure committed to supporting innovation in biomedicine and nanotechnology, NANBIOSIS actively contributes to initiatives that strengthen technology transfer and facilitate access to funding opportunities for researchers, companies and public institutions. Participation in events such as this reinforces NANBIOSIS’ commitment to fostering innovation ecosystems and promoting collaboration between research and industry.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
